Lyn is a target gene for prostate cancer: sequence-based inhibition induces regression of human tumor xenografts.
D000818:Animals; D045744:Cell Line, Tumor; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008819:Mice, Nude; D009842:Oligopeptides / Q000737:chemistry / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology*; D010766:Phosphorylation / Q000187:drug effects; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics*; D023041:Xenograft Model Antitumor Assays; D019061:src-Family Kinases / Q000037:antagonists & inhibitors* / Q000235:genetics*
D004791:Enzyme Inhibitors; D009842:Oligopeptides; D010455:Peptides; C483318:myristyl-glycyl-leucyl-valyl-threonyl-diiodotyrosyl-lysyl-lysyl-isoleucyl-N(epsilon)-benzoyllysinamide; C060902:lyn protein-tyrosine kinase; D019061:src-Family Kinases